Unitaid - The Aurum Institute

5th Global Forum on TB Vaccines - 20 February 2018

Ms Karin Turner, Programme Director for Aurum’s International Programme, UNITAID IMPAACT4TB Project, has been invited to present at the Grant Implementers Forum in Geneva from 28 February to 1 March...
51st Union World Conference on Lung Health

The Aurum Institute is at the 51st Union World Conference on Lung Health. If you are attending the virtual conference, please join us at the sessions listed below. MEDIA INTERVIEWS AND INFORMA...
New patient-friendly tuberculosis preventive therapy to be rolled out in five high-burden TB countries at affordable price

• Fixed-dose combination treatments reduce the pill burden from nine to three pills a week for adults and prevent TB in those at highest risk of developing the disease • Ethiopia, Ghana, Kenya, M...
Aurum launches TB Preventative Treatment rollout in Ghana

Aurum Institute Ghana, recently launched the rollout of 3HP, a new, less toxic, short-course tuberculosis (TB) prevention therapy (TPT). This is part of the IMPAACT4TB project, implemented by a cons...
Improving availability of patient-friendly tuberculosis preventive therapy

Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
TB prevention must be a priority during COVID-19

Members in Action highlights the many areas of work that our members are championing to ensure a better future in lung health. From our Regions, Scientific Sections and member working groups, to the ...
IMPAACT4TB Project statement responding to the WHO Global TB Report 2021

IMPAACT4TB Welcomes Gains in TB Prevention Among People Living With HIV, But Calls for Urgent Action to Address TB Prevention Deficits Among Children and Household Contacts of People Affected by TB ...
Prevention has to be a priority for all diseases, not just the pandemic of the moment

...
Watch: IMPAACT4TB Project 3HP rollout

We have carried Tuberculosis (TB) for far too long, we need to move away from a narrow focus on treatment in order to end TB. Despite TB being both a curable and treatable disease, millions of people...
FIND and Unitaid invest US$ 50 million to speed lifesaving testing and treatment solutions to the COVID-19 pandemic’s frontlines

Geneva, 9 November 2021 – FIND, Unitaid, and partners are joining forces to quickly deliver new end-to-end strategies that will accelerate and enhance improved access to diagnostics and treatment, ...
Fundação Aurum partners with Mozambican government to help end TB

Mozambique has shown its commitment to ending TB, with Prime Minister Carlos Agostinho do Rosário, attending the launch of the rollout of a new TB prevention therapy (TPT) recently. The Aurum Instit...
Call to action for an invigorated drive to scale up TB prevention

...
Aurum at 21st ICASA

Aurum was at the 21st International Conference on AIDS and Sexually Transmitted Infections (STIs) in Africa (ICASA). This year themed; The race to 2030 – Evidence. Scale Up. Accelerate, the conferen...
Aurum at Forum on Microbial Threats workshop

Aurum Group CEO Prof Gavin Churchyard presented at the Forum on Microbial Threats workshop recently. The Forum which is part of the National Academies of Sciences, Engineering, and Medicine, brought...
Aurum Annual Report 2021

Aurum Board Chairperson Ms Phangisile Mtshali characterises 2021 as a year of adapting and building resilience. She writes in the Aurum Annual Report 2021, that the organisation had to pivot and seiz...
Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course

A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...
Concern as TB Preventative Treatment Declines

...
Partners announce reduced price for patient-friendly tuberculosis preventive treatments

August 1, 2022: Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI) and MedAccess today announced two new agreements to lower the price of rifapentine (RPT)-based treatments to p...
Opt4TPT South Africa study team recruits and enrols participants

On 16 September 2021, the Opt4TPT study team in South Africa implemented by The Aurum Institute, started enrolling patients visiting the Chiawelo Community Health Centre (CHC) for antiretroviral the...
Global Consortium welcomes reduced price for patient-friendly treatment to prevent tuberculosis

...